Who invested in Violet Therapeutics?
Violet Therapeutics's investors include Vision Ventures.

United States · Seed startup
Funding summaryUpdated 26 Oct 2026
$15Mraised across 2 rounds since 2023, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
Source recordedSEC filing: $7.4M sold, first sale Apr 2023
From Violet Therapeutics's own website and the SEC filings it signed: 6 on the team.
On the board, as filediAtsushi UsamiJonathan Behr
AdvisersDarby SchmidtEvan LeboisJames Summers
Violet Therapeutics's investors include Vision Ventures.
Violet Therapeutics has raised $15M across 2 rounds since 2023.
Violet Therapeutics's most recent round was a Seed of $4.8M in May 2026.
Violet Therapeutics's largest round on record is $11M (Seed), in May 2023.
Violet Therapeutics's first round on record, in May 2026, was backed by Vision Ventures.
Violet Therapeutics's latest named round is a Seed, in May 2026.
Violet Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.